BACKGROUND: African American men with chronic kidney disease (CKD) progress to end-stage renal disease more rapidly than African American women or whites. Uncontrolled hypertension worsens CKD, and disparities in hypertension control may contribute to disparities in CKD progression. STUDY DESIGN: Cross-sectional. SETTING & PARTICIPANTS: 10,827 individuals with CKD and self-reported hypertension screened in the Kidney Early Evaluation Program. PREDICTORS: African American race, sex. OUTCOMES: Hypertension control (blood pressure <130 mm Hg systolic and/or <80 mm Hg diastolic). MEASUREMENTS: Self-report, physical examination (blood pressure), laboratory data (serum creatinine, microalbuminuria by urine dipstick). We calculated estimated glomerular filtration rates by using the 4-variable isotope dilution mass spectrometry Modification of Diet in Renal Disease Study equation. We classified CKD as early (stages 1 to 2) or late (stages 3 to 5) based on estimated glomerular filtration rate and microalbuminuria. RESULTS: In individuals with early CKD, African American women (odds ratio [OR], 1.47; 95% confidence interval [CI], 1.14 to 1.88), white men (OR, 1.85; 95% CI, 1.39 to 2.46), and white women (OR, 1.69; 95% CI, 1.28 to 2.22) had greater odds of hypertension control (blood pressure <130/80 mm Hg) than African American men. In individuals with late CKD, white men (OR, 1.66; 95% CI, 1.10 to 2.52) and white women (OR, 1.67; 95% CI, 1.13 to 2.46) had greater odds of hypertension control than African American men. No differences were seen between African American men and women with late CKD. LIMITATIONS: No information for medication regimens. CONCLUSIONS: African American men with CKD have poorly controlled hypertension compared with African American women and whites, particularly in the early stages of disease. Efforts to aggressively treat hypertension in this population may help narrow the race and sex disparities in progression to end-stage renal disease.
BACKGROUND: African American men with chronic kidney disease (CKD) progress to end-stage renal disease more rapidly than African American women or whites. Uncontrolled hypertension worsens CKD, and disparities in hypertension control may contribute to disparities in CKD progression. STUDY DESIGN: Cross-sectional. SETTING & PARTICIPANTS: 10,827 individuals with CKD and self-reported hypertension screened in the Kidney Early Evaluation Program. PREDICTORS: African American race, sex. OUTCOMES: Hypertension control (blood pressure <130 mm Hg systolic and/or <80 mm Hg diastolic). MEASUREMENTS: Self-report, physical examination (blood pressure), laboratory data (serum creatinine, microalbuminuria by urine dipstick). We calculated estimated glomerular filtration rates by using the 4-variable isotope dilution mass spectrometry Modification of Diet in Renal Disease Study equation. We classified CKD as early (stages 1 to 2) or late (stages 3 to 5) based on estimated glomerular filtration rate and microalbuminuria. RESULTS: In individuals with early CKD, African American women (odds ratio [OR], 1.47; 95% confidence interval [CI], 1.14 to 1.88), white men (OR, 1.85; 95% CI, 1.39 to 2.46), and white women (OR, 1.69; 95% CI, 1.28 to 2.22) had greater odds of hypertension control (blood pressure <130/80 mm Hg) than African American men. In individuals with late CKD, white men (OR, 1.66; 95% CI, 1.10 to 2.52) and white women (OR, 1.67; 95% CI, 1.13 to 2.46) had greater odds of hypertension control than African American men. No differences were seen between African American men and women with late CKD. LIMITATIONS: No information for medication regimens. CONCLUSIONS: African American men with CKD have poorly controlled hypertension compared with African American women and whites, particularly in the early stages of disease. Efforts to aggressively treat hypertension in this population may help narrow the race and sex disparities in progression to end-stage renal disease.
Authors: J Lewis; L Agodoa; D Cheek; T Greene; J Middleton; D O'Connor; A Ojo; R Phillips; M Sika; J Wright Journal: Am J Kidney Dis Date: 2001-10 Impact factor: 8.860
Authors: Wendy Weinstock Brown; Rosalind M Peters; Suzanne E Ohmit; William F Keane; Allan Collins; Shu-Chen Chen; Karren King; Michael J Klag; Donald A Molony; John M Flack Journal: Am J Kidney Dis Date: 2003-07 Impact factor: 8.860
Authors: Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan Journal: Ann Intern Med Date: 2003-07-15 Impact factor: 25.391
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: David L Mount; Cralen Davis; Betty Kennedy; Susan Raatz; Kathy Dotson; Tiffany L Gary-Webb; Sheikilya Thomas; Karen C Johnson; Mark A Espeland Journal: Clin Trials Date: 2011-11-07 Impact factor: 2.486
Authors: Anand Prasad; Paul Clopton; Colby Ayers; Amit Khera; James A de Lemos; Joseph L Witztum; Sotirios Tsimikas Journal: Arterioscler Thromb Vasc Biol Date: 2017-05-04 Impact factor: 8.311
Authors: Gabriel S Tajeu; Stephen Mennemeyer; Nir Menachemi; Robert Weech-Maldonado; Meredith Kilgore Journal: Med Care Date: 2017-06 Impact factor: 2.983
Authors: Liran I Shlush; Sivan Bercovici; Walter G Wasser; Guennady Yudkovsky; Alan Templeton; Dan Geiger; Karl Skorecki Journal: BMC Med Genomics Date: 2010-10-18 Impact factor: 3.063
Authors: Jessica L Michal; Saira Rab; Manish Patel; Alison W Kyle; Lesley S Miller; Kirk A Easley; Aley G Kalapila Journal: AIDS Res Hum Retroviruses Date: 2018-06-19 Impact factor: 2.205
Authors: Laura C Plantinga; Edgar R Miller; Lesley A Stevens; Rajiv Saran; Kassandra Messer; Nicole Flowers; Linda Geiss; Neil R Powe Journal: Hypertension Date: 2009-05-26 Impact factor: 10.190